A Phase II Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque Psoriasis

Conditions: Psoriasis; Skin Diseases Interventions: Drug: AK111; Drug: AK111 Sponsors: Akeso Not yet recruiting

Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials